Vendor Intelligence Report: China Peptides Supplier

Published 3 Jul 2026. 19-page investigative report on who is behind China Peptides Supplier: corporate records, ownership, affiliate networks, and the vendor's lab-testing record. The first 3 pages are free to read on this page.

Researched and published by Finnrick Analytics. Reports draw on corporate records, affiliate-network analysis, and Finnrick's own laboratory testing record; vendors can challenge findings through the formal objections process at finnrick.com/vendor-support/objections.

Executive summary

Across 4 Finnrick lab tests, China Peptides Supplier's overall pass rate is 75%. That is a narrow record, not a broad catalog endorsement: every tested sample in this dossier is Tirzepatide, with one failure in a small set. For buyers already looking at this source, Tirzepatide is the only partially evidenced option; other DanKang/China Peptide catalog items should not inherit that signal.

The rest of the file shifts the question from purity marketing to counterparty risk. China Peptides Supplier appears as a Facebook-first seller inside a wider China Peptide / DanKang cluster, with a Vietnam-country-code phone reused across multiple pages, Central Nyack address variants, and a website story centered on a Shenzhen facility. Registry and policy checks did not surface the buyer-facing corporate anchors that would normally make those claims easier to test.

Domain forensics show a recent, one-year, privacy-protected DanKang web registration on shared Hong Kong nameservers, plus a free-provider sales email and a privacy-policy path that returned 404. The site now warns buyers to verify seller identity before ordering, but the report found no canonical official-channel list, authorized-reseller list, batch-authentication portal, or signed COA verification system.

The highest operational concern is fulfillment. A public Reddit complaint thread tied to the DanKang domain describes large prepaid orders, partial or missing shipments, alleged losses in the $1,400-$1,700 range, and pressure to cancel bank disputes; the aliases Iris and Lina recur in that trail. The lab chart is therefore only one part of the buying decision: payment recoverability and identity verification matter just as much here.

Inside the full report:

  • Finnrick Tirzepatide record, methodology-divergence chart, trajectory chart, and Appendix A lab table
  • Dated event trail covering the Facebook profile, DanKang site captures, WHOIS record, and complaint review
  • Phone-pivot analysis of the China Peptide / DanKang Facebook page and address cluster
  • Domain and infrastructure review for dankangpeptidesourcefactory.com, including nameservers and expiry watch
  • Fulfillment-complaint analysis covering Reddit allegations, sales aliases Iris and Lina, and the dispute-pressure sequence
  • Registry-search and verification-gap review: OpenCorporates, Delaware, New York, privacy-policy 404, and official-channel controls

Risk assessment

  • Tirzepatide batch-reliability concern — medium: The only Finnrick-tested product is Tirzepatide: 4 tests, 3 pass / 1 fail, 78.41%; no Finnrick support is shown for the rest of the catalog.
  • Fulfillment fraud and dispute-suppression concern — high: Captured Reddit reports tied to the DanKang domain describe $1,400-$1,700 losses, non-delivery or partial shipment, and pressure to cancel bank disputes; sales aliases Iris and Lina are named.
  • Deceptive identity and official-channel verification concern — high: A Facebook/DanKang page cluster shares a +84 Vietnam phone while using Central Nyack address variants and Shenzhen facility claims; no official-channel or authorized-reseller list was found.
  • Unverifiable legal entity and disposable infrastructure concern — medium: Domain was created Nov. 19, 2025 for a one-year term with privacy-protected CN registrant data; registry searches found no public entity and the privacy-policy page returned 404.